A blood test vial being held up in a clinical lab, representing ApoB optimal range testing for cardiovascular longevity
|

ApoB Optimal Range: What Your Number Should Be

Photo by Malcolm Choong 鍾声耀 on Unsplash

By The Longevity Dose Editorial Team · Evidence-reviewed · Last updated July 2026

Your ApoB number is, right now, probably the single most important cholesterol-related number your doctor isn’t measuring. Most standard lipid panels report LDL cholesterol — but ApoB optimal range targets tell a more precise story about cardiovascular risk, and the threshold you should actually be aiming for is significantly lower than what most labs flag as “normal.” Dr. Peter Attia at Early Medical has been making this case for years, and the evidence increasingly backs him up.

Key Takeaways

  • ApoB measures the total number of atherogenic lipoprotein particles in your blood — a more reliable cardiovascular risk marker than LDL-C alone.
  • Most labs consider ApoB under 100 mg/dL “normal,” but for longevity-focused adults, a target of 60–80 mg/dL is increasingly supported by cardiovascular outcome data.
  • Diet, exercise, and statins or PCSK9 inhibitors can all meaningfully lower ApoB — the most effective strategy depends on your baseline and risk profile.
  • ApoB testing is not included in a standard lipid panel; you need to ask for it specifically, and many insurers now cover it.

What Is ApoB and Why Does It Matter More Than LDL?

Apolipoprotein B is the structural protein that sits on the surface of every atherogenic lipoprotein particle — every LDL, VLDL, IDL, and Lp(a) particle in your blood carries exactly one ApoB molecule. That means ApoB is essentially a direct count of the particles that can penetrate arterial walls and trigger plaque buildup.

LDL cholesterol (LDL-C), by contrast, measures the total cholesterol cargo carried inside those particles. Two people can have identical LDL-C numbers but very different particle counts — and very different risk profiles. The person with more, smaller LDL particles will have higher ApoB and higher risk, even though their LDL-C looks the same on paper.

This is why researchers at institutions like the European Society of Cardiology now recommend ApoB as the preferred measure for assessing cardiovascular risk. Evidence shows that ApoB is a stronger predictor of heart attack and stroke than LDL-C, particularly in people who appear low-risk on standard panels. If you’re tracking your longevity biomarkers, ApoB belongs near the top of that list.

What Is the ApoB Optimal Range for Longevity?

Here’s where it gets important. Labs typically flag anything under 100 mg/dL as within normal limits. But “normal” means average for a population where heart disease is the leading cause of death. That’s not the target you want.

For longevity-focused adults, the picture looks like this:

ApoB Level (mg/dL) What It Means Who It Applies To
Above 120 Elevated risk — action warranted Anyone
100–120 Borderline — worth addressing General population
80–100 Acceptable but not optimal Lower-risk adults
60–80 Longevity-focused target Health-optimizing adults
Below 60 Aggressive target for high-risk individuals Existing CVD or very high genetic risk

Dr. Peter Attia recommends pushing ApoB to around 60 mg/dL or lower for people serious about cardiovascular longevity — a position outlined clearly in his book Outlive: The Science and Art of Longevity, which remains the most practical framework available for understanding these targets and acting on them.

European guidelines for patients with established coronary heart disease set an LDL-C goal of under 55 mg/dL, with corresponding ApoB below 65 mg/dL. A 2025 observational study published in the European Journal of Preventive Cardiology (PMID 40796307) found that across 14 countries, only a minority of patients with coronary heart disease were actually reaching these guideline-recommended lipid goals — meaning even high-risk patients are being undertreated globally.

How to Get an ApoB Test

ApoB is not part of a standard lipid panel. You have to ask for it. The good news: most major insurers in the U.S. now cover it, especially if you have cardiovascular risk factors or a family history of heart disease.

Here’s how to get tested:

  1. Ask your doctor at your next annual physical. Frame it as: “Can you add ApoB to my bloodwork this year?” Most primary care physicians will agree.
  2. Order directly if needed. Services like Quest Diagnostics and LabCorp allow you to order ApoB tests without a physician referral in most U.S. states. Cost is typically $25–$50 out of pocket.
  3. Test fasted. While ApoB is less affected by fasting than triglycerides, a 9–12 hour fast before the draw is standard practice and ensures consistency.
  4. Track it over time. A single reading is useful. Serial measurements every 6–12 months are far more valuable for understanding your trajectory.

Importantly, a 2026 study in Clinical Chemistry (PMID 42201254) highlighted that previous international reference measurement procedures for ApoB standardization were no longer functional, and a new validated multiplex LC-MRM-MS method has been developed to improve accuracy across labs. This matters practically: results from different labs may have varied slightly in the past. As this new standardization rolls out, ApoB measurements will become even more comparable and reliable.

What the Research Shows: ApoB as a Causal Risk Factor

One of the strongest arguments for taking ApoB seriously is the Mendelian randomization evidence. This type of genetic analysis essentially uses natural genetic variation as a quasi-experiment — people born with genes that lower ApoB tend to have dramatically lower lifetime cardiovascular risk, proportional to the duration and magnitude of that lower exposure.

The causal logic is clear: lower ApoB over a lifetime equals fewer atherogenic particles, less endothelial penetration, less plaque. That’s not a correlation — it’s mechanism-supported causation.

A 2025 study in the European Journal of Preventive Cardiology (PMID 39921475) also found that ApoC3 levels — a related apolipoprotein — independently predicted major adverse cardiovascular events in over 11,000 patients with acute coronary syndrome, even in those on optimized statin therapy. This finding reinforces the broader principle: total particle burden (not just LDL-C) determines cardiovascular outcomes.

Furthermore, the data on early intervention is compelling. Cardiovascular atherosclerosis begins silently in your 20s and 30s. Waiting until your 50s to address ApoB means decades of particle accumulation you can’t undo. Starting earlier — even with modest reductions — has disproportionately large lifetime benefits.

Practical Protocol: How to Lower Your ApoB

Lowering ApoB involves a mix of dietary changes, exercise, and in some cases medication. Here’s what the evidence supports, in order of impact:

1. Reduce Saturated Fat Intake

Saturated fat is the primary dietary driver of elevated ApoB. Replacing saturated fat with unsaturated fat (particularly olive oil, nuts, and fatty fish) consistently lowers LDL particle count and ApoB. Evidence shows the magnitude of this effect is modest — typically a 5–15% reduction — but meaningful as a foundation. Pair this with your broader longevity dietary strategy.

2. Add Soluble Fiber

Soluble fiber (from oats, psyllium husk, beans, and lentils) reduces intestinal cholesterol absorption and lowers LDL-C and ApoB. Psyllium husk at 10–12 grams per day has been shown in multiple trials to reduce LDL-C by roughly 5–10%. It’s cheap, safe, and underused.

3. Exercise — Especially Zone 2 Cardio

Regular aerobic exercise improves lipid metabolism and lowers ApoB, primarily by reducing VLDL production and raising HDL-mediated clearance. The effect is real but modest — exercise alone rarely drops ApoB by more than 5–10%. That said, Zone 2 cardio training provides compounding benefits for cardiovascular health that go well beyond lipid numbers.

4. Statins: The Most Effective Non-Genetic Lever

High-intensity statins (rosuvastatin 20–40 mg, atorvastatin 40–80 mg) can lower ApoB by 40–55% in many people. For anyone who cannot reach their ApoB target through lifestyle alone, statins are well-supported by decades of human outcome data. The conversation about whether healthy adults should use statins preventively is evolving — talk to your doctor about where you stand.

5. PCSK9 Inhibitors for High-Risk Individuals

Injectable PCSK9 inhibitors (evolocumab, alirocumab) can lower LDL-C and ApoB by 50–60% on top of statin therapy. These are currently reserved for high-risk patients or those with familial hypercholesterolemia, but costs have fallen significantly and oral PCSK9 inhibitors are now entering clinical use in 2026.

What We Don’t Know Yet

Honesty matters here. The specific ApoB target of 60 mg/dL for otherwise-healthy adults is not yet backed by long-term randomized controlled trials in that population. The longevity targets are extrapolated from cardiovascular outcome data in high-risk cohorts and from genetic studies — not from RCTs that followed healthy 40-year-olds for 30 years.

We also don’t have strong data on whether very low ApoB (below 40 mg/dL) carries any risks for healthy adults. In rare genetic conditions that cause extremely low ApoB (abetalipoproteinemia), fat-soluble vitamin absorption suffers. Whether pharmacologically induced very low levels matter for healthy people is unknown.

And the interaction between ApoB, Lp(a), and other emerging risk markers is still being mapped. ApoB is the best single metric we have right now — but cardiovascular risk is multifactorial, and the full picture includes Lp(a), blood pressure, metabolic health, and inflammation.

Affiliate Disclosure: The Longevity Dose may earn a small commission if you purchase through the links below, at no additional cost to you. We only recommend products we genuinely believe in. Learn more.

What We Recommend

  • Outlive: The Science and Art of Longevity — Dr. Peter Attia. If you’re serious about understanding your ApoB target and building a personal cardiovascular longevity strategy, this is the book. Dr. Attia covers ApoB, Lp(a), and lipid management in more practical depth than any other consumer resource available.
  • Lifespan: Why We Age — David Sinclair. Dr. Sinclair’s book provides the broader aging science framework — essential context for understanding why cardiovascular health and ApoB control matter so much for longevity, not just avoiding heart attacks.
Medical Disclaimer: The content on The Longevity Dose is for informational and educational purposes only. It is not medical advice and should not replace consultation with a qualified healthcare provider. Always speak with your doctor before starting any new supplement, exercise, or health protocol, especially if you have an existing medical condition or take medications. Read our full health disclaimer.

Frequently Asked Questions

What is a good ApoB level for a healthy adult?

For longevity-focused adults without existing cardiovascular disease, an ApoB in the range of 60–80 mg/dL is considered optimal by most preventive cardiologists, including Dr. Peter Attia. Standard lab reference ranges flag below 100 mg/dL as normal, but “normal” reflects population averages — not the lowest-risk target. Talk to your doctor about what’s right for your individual risk profile.

Is ApoB better than LDL cholesterol for predicting heart disease risk?

Evidence shows ApoB is generally a stronger predictor of cardiovascular events than LDL-C, particularly in people with metabolic syndrome, insulin resistance, or high triglycerides. LDL-C can underestimate risk in people with many small, dense LDL particles. ApoB counts those particles directly, giving a more complete picture of atherogenic burden.

How do I get my ApoB tested?

ApoB is not included in a standard lipid panel — you need to request it specifically from your doctor or order it directly through a lab service like Quest or LabCorp. Cost is typically $25–$50 out of pocket, and many insurers cover it with cardiovascular risk factors present. Fasting for 9–12 hours before the draw is standard practice.

Can diet and exercise alone bring ApoB into the optimal range?

For some people, yes. Reducing saturated fat, increasing soluble fiber (such as 10–12 g/day of psyllium husk), and consistent aerobic exercise can collectively reduce ApoB by 10–25%. But many people — especially those with genetic predispositions — will need medication like a statin to reach a target of 60–80 mg/dL. Lifestyle and medication are not mutually exclusive strategies.

What’s the difference between ApoB and Lp(a)?

ApoB measures all atherogenic lipoprotein particles and can be lowered by lifestyle and medication. Lp(a) is a genetically determined lipoprotein that ApoB testing includes but doesn’t specifically quantify. Lp(a) is largely fixed by your genes and doesn’t respond to statins the way LDL does — it requires a separate Lp(a) blood test and its own management strategy. Both matter for cardiovascular longevity.

How often should I test ApoB?

If your ApoB is already in the optimal range and you’re not on lipid-lowering therapy, testing once a year alongside your annual physical is reasonable. If you’ve made dietary changes or started medication, retesting every 3–6 months lets you confirm the intervention is working. Serial measurements over time are more meaningful than any single data point.

Liked This? Keep Reading.

Get the next post in your inbox. Real science on longevity, supplements, and fitness — no hype.

Drop your email below. Weekly. No spam. Unsubscribe anytime. ↓

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *